Approval · Notice of Compliance 846 · 2002
VIVOTIF: Notice of Compliance 846
Issued May 2, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 846
- Date
- May 2, 2002
- Company
- Berna Biotech Ltd.Bern, Bern, Switzerland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Active immunizing agent
Products in this notice
Medicinal ingredients
- TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A 10 B per CAP
- TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A 10 B per PCK